journal article·2022-07Open access

DNA Origami Nanostructures Elicit Dose‐Dependent Immunogenicity and Are Nontoxic up to High Doses In Vivo

Christopher R. Lucas, Patrick D. Halley, Amjad A. Chowdury, Bonnie K. Harrington, Larry Beaver, Rosa Lapalombella, Amy J. Johnson, Erin K. Hertlein, Mitch A. Phelps, John C. Byrd, Carlos E. Castro

Small· Volume 18· Issue 26

Abstract

Abstract DNA origami (DO) nanotechnology enables the construction of precise nanostructures capable of functionalization with small molecule drugs, nucleic acids, and proteins, suggesting a promising platform for biomedical applications. Despite the potential for drug and vaccine delivery, the impact of DO vehicles on immunogenicity in vivo is not well understood. Here, two DO vehicles, a flat triangle and a nanorod, at varying concentrations are evaluated in vitro and with a repeated dosing regimen administered at a high dose in vivo to study early and late immunogenicity. The studies show normal CD11b+ myeloid cell populations preferentially internalize DO in vitro. DO structures distribute well systemically in vivo, elicit a modest pro‐inflammatory immune response that diminishes over time and are nontoxic as shown by weight, histopathology, lack of cytokine storm, and a complete biochemistry panel at the day 10 end point. The results take critical steps to characterize the biological response to DO and suggest that DO vehicles represent a promising platform for drug delivery and vaccine development where immunogenicity should be a key consideration.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · Immunotherapy and Immune Responses

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Mechanical and Aerospace Engineering Comprehensive Cancer Center The Ohio State University Columbus Columbus OH 43210 USA

Department of Mechanical and Aerospace Engineering The Ohio State University Columbus OH 43210 USA

Comprehensive Cancer Center College of Veterinary Medicine The Ohio State University Columbus OH 43210 USA

Comprehensive Cancer Center The Ohio State University Columbus OH 43210 USA

Division of Pharmaceutics and Pharmaceutical Chemistry College of Pharmacy The Ohio State University Columbus OH 43210 USA

Department of Mechanical and Aerospace Engineering Biophysics Graduate Program Department of Physics The Ohio State University Columbus OH 43210 USA

Funding

National Institutes of Health

References (57)

Show source-provided references
1. 10.1038/nrc.2016.10810.1038/nrc.2016.108 ↗
2. 10.1186/s40169-017-0175-010.1186/s40169-017-0175-0 ↗
3. 10.3389/fphar.2015.0028610.3389/fphar.2015.00286 ↗
4. 10.1186/1556-276X-8-10210.1186/1556-276X-8-102 ↗
5. 10.1186/s12951-018-0392-810.1186/s12951-018-0392-8 ↗
6. 10.2174/138920102066619041712510110.2174/1389201020666190417125101 ↗
7. 10.1146/annurev-med-040210-16254410.1146/annurev-med-040210-162544 ↗
8. 10.1038/nrd259110.1038/nrd2591 ↗
9. 10.1038/nrd261410.1038/nrd2614 ↗
10. 10.1158/0008-5472.CAN-12-168310.1158/0008-5472.CAN-12-1683 ↗
11. 10.1080/1042819050005243810.1080/10428190500052438 ↗
12. 10.1021/nn302266210.1021/nn3022662 ↗
13. 10.1021/ja304263n10.1021/ja304263n ↗
14. 10.1021/nn502058j10.1021/nn502058j ↗
15. 10.1002/smll.20150211810.1002/smll.201502118 ↗
16. 10.1021/acsmedchemlett.8b0055710.1021/acsmedchemlett.8b00557 ↗
17. 10.1126/science.121408110.1126/science.1214081 ↗
18. 10.1038/s41565-018-0336-310.1038/s41565-018-0336-3 ↗
19. 10.1038/nbt.407110.1038/nbt.4071 ↗
20. 10.1038/nature0458610.1038/nature04586 ↗
21. 10.1038/nmeth.157010.1038/nmeth.1570 ↗
22. 10.1002/adma.20150473310.1002/adma.201504733 ↗
23. 10.3390/cancers1112199710.3390/cancers11121997 ↗
24. 10.1038/s41565-020-0719-010.1038/s41565-020-0719-0 ↗
25. 10.1038/s41563-020-0793-610.1038/s41563-020-0793-6 ↗
26. 10.1073/pnas.181829011610.1073/pnas.1818290116 ↗
27. 10.1002/anie.20200984210.1002/anie.202009842 ↗
28. 10.1016/j.immuni.2013.05.00410.1016/j.immuni.2013.05.004 ↗
29. 10.1038/nnano.2015.18010.1038/nnano.2015.180 ↗
30. 10.1021/nn203161y10.1021/nn203161y ↗
31. 10.1021/nn501191410.1021/nn5011914 ↗
32. 10.1007/s12274-019-2384-x10.1007/s12274-019-2384-x ↗
33. 10.1021/nn202774x10.1021/nn202774x ↗
34. 10.1016/j.biopha.2019.10865710.1016/j.biopha.2019.108657 ↗
35. 10.1002/eji.20164683710.1002/eji.201646837 ↗
36. 10.1002/eji.20032403210.1002/eji.200324032 ↗
37. 10.1016/j.imbio.2004.02.00610.1016/j.imbio.2004.02.006 ↗
38. 10.1038/s41598-019-40689-110.1038/s41598-019-40689-1 ↗
39. 10.1016/j.immuni.2014.12.02710.1016/j.immuni.2014.12.027 ↗
40. 10.1038/ncomms1565410.1038/ncomms15654 ↗
41. 10.1016/j.iac.2009.02.00610.1016/j.iac.2009.02.006 ↗
42. 10.1038/s41551-018-0317-810.1038/s41551-018-0317-8 ↗
43. 10.1038/laban0209-4910.1038/laban0209-49 ↗
44. 10.1080/1528739860953085910.1080/15287398609530859 ↗
45. 10.1293/tox.2017-003810.1293/tox.2017-0038 ↗
46. 10.1038/sj.ki.500198810.1038/sj.ki.5001988 ↗
47. 10.1111/j.1523-1755.2004.00600.x10.1111/j.1523-1755.2004.00600.x ↗
48. 10.1371/journal.pone.025043810.1371/journal.pone.0250438 ↗
49. 10.1016/j.ctrv.2017.11.00710.1016/j.ctrv.2017.11.007 ↗
50. 10.1038/3504712310.1038/35047123 ↗
51. 10.1002/anie.20160887310.1002/anie.201608873 ↗
52. 10.1016/j.jconrel.2019.05.02110.1016/j.jconrel.2019.05.021 ↗
53. 10.1093/nar/gkp43610.1093/nar/gkp436 ↗
54. 10.1002/anie.20140599110.1002/anie.201405991 ↗
55. 10.1002/9780470559277.ch12023510.1002/9780470559277.ch120235 ↗
56. 10.1182/bloodadvances.201802568410.1182/bloodadvances.2018025684 ↗
57. 10.1182/blood-2018-04-84542010.1182/blood-2018-04-845420 ↗